On ECHEMI
Home > Drugs > Malotidate extended-release tablets

Malotidate extended-release tablets

Function and Efficacy

According to foreign literature reports: Pharmacological action: Acting on liver cells, it has the effect of promoting RNA synthesis and increasing ribosome activity, and plays a role in improving protein metabolism, which can improve liver function and inhibit the process of liver fibrosis. Toxicological action: Rats took 100-300 mg/kg orally for 52 weeks, which can cause erythropenia and increased liver weight; dogs took 100-500 mg/kg orally for 52 weeks, which can cause vomiting, increased liver weight, and iron-containing hemoglobin deposition in the spleen. Rats were given 320 mg/kg of malotiate orally, and before pregnancy and early pregnancy, maternal weight gain was inhibited and fetal ossification was slightly delayed; during the perinatal period and lactation period, maternal and neonatal weight gain was inhibited. No abnormalities were found in antigenicity tests, mutagenicity tests, and general pharmacology tests.

Ingredients

Malotiate

Name Description Content CAS NO. Manufacturer
MalotilateIngredients

It acts on liver cells, promotes RNA synthesis and increases ribosome activity, improves protein metabolism, and can improve liver function while inhibiting the progression of liver fibrosis.

More
59937-28-9 4

Appearance

This product is light yellow tablet.

Indication

It is suitable for chronic hepatitis, cirrhosis, liver damage caused by advanced schistosomiasis and hypoproteinemia complicated by pulmonary tuberculosis.

Usage and Dosage

Oral administration. 2 tablets twice a day.

Adverse Reactions

Digestive tract: sometimes it may cause loss of appetite, nausea, vomiting, stomach discomfort, abdominal distension, diarrhea, thirst, etc., and occasionally constipation. Liver: sometimes it may cause jaundice, increased GOT, GPT, etc. after taking the medicine. Therefore, if the above symptoms appear after administration, the medicine should be stopped immediately and appropriate treatment should be taken. Allergy: sometimes it may cause rash, itching, etc. Nervous system: sometimes it may cause drowsiness, headache, occasional dizziness, cramps, etc. Blood system: sometimes it may cause leukopenia, erythropenia, increase in eosinophils, and occasionally thrombocytopenia. Others: sometimes there may be fatigue, fever, etc.

Precautions

It is contraindicated for patients with jaundice, ascites, children, pregnant women, lactating women and those who are allergic to this product.

Special Population Medication

Precautions for children: Children are prohibited from using this product. Precautions for pregnancy and lactation: Pregnant women and lactating women are prohibited from using this product. Precautions for the elderly: Because the physiological functions of elderly patients are low, they should follow the doctor's advice and reduce the dosage.

Drug Interactions

Not yet clear.

Storage

Keep tightly closed.

Packaging Specification

0.15g

Validity Period

Tentative 24 months

Manufacturer

Yabao Pharmaceutical Group Co., Ltd.

  • Founded in:

    1999-01-26
  • Address:

    No. 43, Fumin Road, Ruicheng County, Yuncheng City, Shanxi Province
  • Tax NO.:

    91140000701108049W
  • Registered Funds:

    720,000,940 yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.